STOCK TITAN

Butterfly Network, Inc. - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Butterfly Network, Inc. (BFLY) is revolutionizing the healthcare landscape with its innovative digital health solutions, primarily focused on handheld, whole-body ultrasound technology. The company, which operates at the nexus of advanced engineering and scientific disciplines, has assembled a team of world-class talents in computer science, physics, and electrical engineering. Underpinned by a robust financial foundation from a select group of highly successful serial entrepreneurs, Butterfly Network is uniquely positioned to dedicate its full attention to product and intellectual property development.

Butterfly Network's flagship product, the Butterfly iQ+, represents a significant leap in medical imaging technology. This compact, user-friendly device leverages the company's proprietary Ultrasound-on-Chip technology to enable healthcare professionals to perform comprehensive whole-body imaging using a single handheld probe. The device's affordability and portability make it a game-changer in clinical settings, ensuring that high-quality ultrasound imaging is accessible and practical for a wide range of medical applications.

The integration of cloud-connected software with hardware technology further enhances the utility of the Butterfly iQ+, allowing for seamless data acquisition and analysis via a mobile application. This connectivity facilitates the practical application of ultrasound information within clinical workflows, thereby improving diagnostic capabilities and patient outcomes.

Recent achievements and ongoing projects include advancements in ultrasound technology and the expansion of the product's applications in various medical fields. The company's commitment to innovation is reflected in its continuous efforts to enhance the performance and capabilities of its devices.

With a strong focus on R&D and a strategic approach to technological development, Butterfly Network is poised to make significant contributions to digital health and medical imaging. The company's progress and updates can be closely followed through the latest news and press releases, which provide valuable insights into its performance, events, and developments.

Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the TD Cowen 44th Annual Health Care Conference in Boston on March 5, 2024. Joseph DeVivo and Heather Getz will present the company's handheld ultrasound technology and software. Investors can schedule one-on-one meetings with the executives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) will host an Investor Day on March 18, 2024, at the New York Stock Exchange. The event will showcase their product portfolio, strategic initiatives, and new Butterfly iQ3™. Key executives will present, along with strategic partners introducing AI tools and products in development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will report Q4 and full year 2023 financial results on February 28, 2024. An Investor Day is scheduled for March 18, 2024, at the New York Stock Exchange, showcasing the latest ultrasound technology and co-developed products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.19%
Tags
conferences earnings
Rhea-AI Summary
Butterfly Network, Inc. launches Butterfly iQ3, a third-generation handheld point-of-care ultrasound system powered by advanced semiconductor chip technology. The device offers unparalleled image quality, faster micro-beamforming, and new 3D imaging capabilities. Butterfly iQ3 is available for purchase in the United States at $3,899 plus membership, aiming to revolutionize point-of-care ultrasound with enhanced comfort, efficiency, and innovative tools.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.08%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) expects to exceed 2023 revenue and adjusted EBITDA guidance. The company showcased the sharp image quality of its newly FDA-cleared, third-generation probe, Butterfly iQ3, and introduced iQ Slice, the world’s first automated, sequential image capture mode on a handheld ultrasound, launching with Butterfly iQ3. Joseph DeVivo, Butterfly Network’s President, CEO, and Chairman, expressed confidence in the team's performance and energy, leading to the expectation of exceeding the 2023 guidance provided. The company’s previously issued guidance for the full year 2023 was revenue of at least $64 million, and an improved adjusted EBITDA loss of $75 - 70 million. Butterfly also announced FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3, and expects to launch it this quarter (Q1 2024).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announces FDA clearance for Butterfly iQ3, a next-generation handheld point-of-care ultrasound system. The new device features advanced semiconductor technology, improved image resolution, sensitivity, and penetration, as well as faster 3D capabilities. It also introduces novel, automated image capture modes: iQ Slice and iQ Fan. Butterfly iQ3 is set to revolutionize digital ultrasound and make it more accessible and approachable than ever before.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.79%
Tags
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. The company is a digital health company specializing in handheld, whole-body ultrasound and intuitive software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) and Mendaera partner to bring Butterfly’s Ultrasound-on-Chip™ to the robotic intervention market, with revenue anticipated from every unit sold. The partnership aims to streamline patient care by improving precision and consistency for a broad range of image-guided, needle-based interventions. FDA submission of the product is anticipated by 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.13%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-11, 2024, in San Francisco. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on January 11, 2024, at 9:00 AM PST. A webcast of the presentation will be available on the Butterfly investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate at the Jefferies London Healthcare Conference on November 14-16, 2023. CEO Joseph DeVivo and CFO Heather Getz will present on November 14 at 3:30 PM GMT. A live webcast will be available on the Butterfly Network investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $3.11 as of December 24, 2024.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 662.6M.

What is Butterfly Network, Inc.?

Butterfly Network, Inc. is a digital health company focused on revolutionizing healthcare with its handheld, whole-body ultrasound technology.

What product does Butterfly Network offer?

The company's flagship product is the Butterfly iQ+, a handheld ultrasound device that utilizes proprietary Ultrasound-on-Chip technology for whole-body imaging.

How does the Butterfly iQ+ work?

The Butterfly iQ+ combines a handheld probe with cloud-connected software, allowing healthcare professionals to perform comprehensive whole-body imaging using a mobile application.

What makes Butterfly Network's technology unique?

Butterfly Network's technology is unique due to its Ultrasound-on-Chip technology, which enables high-quality imaging in a compact, affordable device that's easy to use.

Who funds Butterfly Network?

Butterfly Network is privately funded by a small group of extraordinarily successful serial entrepreneurs.

What are the recent achievements of Butterfly Network?

Recent achievements include advancements in ultrasound technology and the expansion of applications for their handheld devices across various medical fields.

How does Butterfly Network contribute to healthcare?

Butterfly Network contributes to healthcare by making high-quality ultrasound imaging accessible and practical, thus improving diagnostic capabilities and patient outcomes.

Is Butterfly Network publicly traded?

Yes, Butterfly Network, Inc. is publicly traded under the symbol BFLY.

Can the Butterfly iQ+ be used in multiple medical settings?

Yes, the Butterfly iQ+ is designed for use in a wide range of medical settings, providing versatile imaging capabilities.

Where can I find the latest news on Butterfly Network?

The latest news and updates on Butterfly Network can be found through their official press releases and stock market updates.

Butterfly Network, Inc.

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

662.62M
155.82M
16.79%
27.56%
5.96%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
BURLINGTON